The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Vaxneuvance
Australian Public Assessment Report
Device/Product Name
Vaxneuvance
Active ingredients
Pneumococcal 15-valent conjugate vaccine (CRM197 protein), adsorbed
AusPAR Date
Published
Submission Number
PM-2020-06364-1-2
Submission Type
New biological entity
Decision
Approved